Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Nature Communications
|
April 24, 2021
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells
Mitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree, et al.
Nature Communications
|
December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
Beau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Molecular Therapy. Oncology
|
January 15, 2026
Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma
Gabrielle M Robbins, Jae-Woong Chang, Joshua B Krueger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 3, 2013
TALEN-based gene correction for epidermolysis bullosa
Mark J Osborn, Colby G Starker, Amber N McElroy, et al.
Nature Biomedical Engineering
|
November 18, 2024
Ablation of FAS confers allogeneic CD3<sup>-</sup> CAR T cells with resistance to rejection by T cells and natural killer cells
Silvia Menegatti, Sheila Lopez-Cobo, Aurelien Sutra Del Galy, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Correction of Fanconi Anemia Mutations Using Digital Genome Engineering
Christopher J Sipe, Mitchell G Kluesner, Samuel P Bingea, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2025
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing
Minjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune Cells
Joseph G Skeate, Nicholas J Slipek, Walker S Lahr, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 28, 2015
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
Mark J Osborn, Beau R Webber, Friederike Knipping, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 17, 2024
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies
Joseph G Skeate, Emily J Pomeroy, Nicholas J Slipek, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Nature Communications
|
April 24, 2021
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells
Mitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree, et al.
Nature Communications
|
December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
Beau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Molecular Therapy. Oncology
|
January 15, 2026
Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma
Gabrielle M Robbins, Jae-Woong Chang, Joshua B Krueger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 3, 2013
TALEN-based gene correction for epidermolysis bullosa
Mark J Osborn, Colby G Starker, Amber N McElroy, et al.
Nature Biomedical Engineering
|
November 18, 2024
Ablation of FAS confers allogeneic CD3<sup>-</sup> CAR T cells with resistance to rejection by T cells and natural killer cells
Silvia Menegatti, Sheila Lopez-Cobo, Aurelien Sutra Del Galy, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Correction of Fanconi Anemia Mutations Using Digital Genome Engineering
Christopher J Sipe, Mitchell G Kluesner, Samuel P Bingea, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2025
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing
Minjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune Cells
Joseph G Skeate, Nicholas J Slipek, Walker S Lahr, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 28, 2015
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
Mark J Osborn, Beau R Webber, Friederike Knipping, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 17, 2024
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies
Joseph G Skeate, Emily J Pomeroy, Nicholas J Slipek, et al.
Page
of 8